TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 96 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $6,859,000 | +2.4% | 69,773 | +20.5% | 0.04% | +2.3% |
| Q2 2018 | $6,701,000 | +26.2% | 57,924 | +7.7% | 0.04% | +4.8% |
| Q1 2018 | $5,311,000 | +13.0% | 53,786 | +19.8% | 0.04% | +27.3% |
| Q4 2017 | $4,701,000 | +4.6% | 44,893 | +12.5% | 0.03% | +3.1% |
| Q3 2017 | $4,496,000 | +8.3% | 39,898 | +7.7% | 0.03% | +10.3% |
| Q2 2017 | $4,150,000 | +3.3% | 37,037 | +4.9% | 0.03% | +3.6% |
| Q1 2017 | $4,016,000 | -3.3% | 35,300 | -10.5% | 0.03% | -9.7% |
| Q4 2016 | $4,151,000 | – | 39,433 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 565,951 | $24,483,000 | 8.44% |
| Murchinson Ltd. | 162,703 | $7,039,000 | 1.34% |
| Eversept Partners, LP | 220,286 | $9,529,572 | 0.73% |
| BRANDES INVESTMENT PARTNERS, LP | 379,322 | $16,410,000 | 0.35% |
| Analyst IMS Investment Management Services Ltd. | 17,657 | $764,000 | 0.07% |
| Claret Asset Management Corp | 7,279 | $315,000 | 0.06% |
| ACADIAN ASSET MANAGEMENT LLC | 326,427 | $14,086,000 | 0.06% |
| Renaissance Technologies | 678,300 | $29,343,000 | 0.03% |
| HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC | 191,820 | $8,298,000 | 0.03% |
| ARK Investment Management | 55,566 | $2,404,000 | 0.01% |